Zhang J, Jiang W, Wang W, Liu C, Hu Y, Xia Z. Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma. Asian Pacific Journal of Cancer Prevention. 2015 Jun 26;16(11):4515–20. doi: 10.7314/apjcp.2015.16.11.4515.
Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma